Antisaccade performance in patients with multiple sclerosis
Joanne Fielding, Trevor Kilpatrick, Lynette Millist, Owen White
CORTEX | ELSEVIER MASSON, CORP OFF | Published : 2009
Commonly used measures of disability in patients with Multiple sclerosis (MS) inadequately reflect disease severity and progression. Further, cognitive deficits experienced by up to 70% of patients, are poorly represented by these measures. Saccadic eye movements may provide a powerful tool for the analysis of cognitive changes in MS, providing a surrogate measure of performance that extends more conventional measures. The cognitive control of eye movements has not previously been investigated in patients with MS. We studied antisaccade (AS) performance in 25 patients with MS and compared the results with 25 age matched healthy controls, to evaluate the resolution of response conflict betwee..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council, Australia
This study was supported by a Fellowship awarded by the National Health and Medical Research Council, Australia (#454811) to Dr. J. Fielding.